Skip to main content
Log in

Bacterial cellulose-based materials and medical devices: current state and perspectives

  • Mini-Review
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

Bacterial cellulose (BC) is a unique and promising material for use as implants and scaffolds in tissue engineering. It is composed of a pure cellulose nanofiber mesh spun by bacteria. It is remarkable for its strength and its ability to be engineered structurally and chemically at nano-, micro-, and macroscales. Its high water content and purity make the material biocompatible for multiple medical applications. Its biocompatibility, mechanical strength, chemical and morphologic controllability make it a natural choice for use in the body in biomedical devices with broader application than has yet been utilized. This paper reviews the current state of understanding of bacterial cellulose, known methods for controlling its physical and chemical structure (e.g., porosity, fiber alignment, etc.), biomedical applications for which it is currently being used, or investigated for use, challenges yet to be overcome, and future possibilities for BC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

Download references

Acknowledgments

ICTAS funding, Project 555053 Bone Healing is acknowledged for financial support.

Author disclosure statement

Dr. Gatenholm is a cofounder of Arterion but no longer associated with the company. He is also cofounder of BC Genesis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul Gatenholm.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Petersen, N., Gatenholm, P. Bacterial cellulose-based materials and medical devices: current state and perspectives. Appl Microbiol Biotechnol 91, 1277–1286 (2011). https://doi.org/10.1007/s00253-011-3432-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-011-3432-y

Keywords

Navigation